Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade
Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade

Atlassian (TEAM) closed the last trading session at $85.42, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $10.35, gaining 16.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's  What You Should Know
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know

Shares of Afya (AFYA) have gained 0.2% over the past four weeks to close the last trading session at $14, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

Adicet Bio, Inc. (ACET) closed the last trading session at $8.3, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) closed the last trading session at $12.11, gaining 18.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%
How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%

Alliance Laundry Holdings (ALH) closed the last trading session at $24.77, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a Bet

Lifezone Metals Limited (LZM) closed the last trading session at $5.09, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Biodesix, Inc. (BDSX) closed the last trading session at $14.93, gaining 40.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?

Shares of BillionToOne (BLLN) have gained 1.4% over the past four weeks to close the last trading session at $85.92, but there could still be a solid upside left in the stock if short-term price

Should You Buy UBS (UBS) After Golden Cross?
Should You Buy UBS (UBS) After Golden Cross?

After reaching an important support level, UBS Group AG (UBS) could be a good stock pick from a technical perspective. UBS recently experienced a "golden cross" event, which saw its 50-day simple

Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade
Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade

Freshworks Inc. (FRSH) closed the last trading session at $9.08, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Concentra (CON) Could Surge 25.24%: Read This Before Placing a Bet
Wall Street Analysts Think Concentra (CON) Could Surge 25.24%: Read This Before Placing a Bet

Shares of Concentra Group (CON) have gained 11% over the past four weeks to close the last trading session at $25.32, but there could still be a solid upside left in the stock if short-term price

Methanex (MEOH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Methanex (MEOH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in Methanex (MEOH) lately. While the stock has lost 5.1% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading

Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet
Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet

Copart, Inc. (CPRT) closed the last trading session at $33.79, gaining 2.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?
Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?

Contineum Therapeutics, Inc. (CTNM) closed the last trading session at $13.86, gaining 11.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Predict a 35.71% Upside in Loar Holdings Inc. (LOAR): Here's  What You Should Know
Wall Street Analysts Predict a 35.71% Upside in Loar Holdings Inc. (LOAR): Here's What You Should Know

Shares of Loar Holdings Inc. (LOAR) have gained 8.8% over the past four weeks to close the last trading session at $62.34, but there could still be a solid upside left in the stock if short-term

Here's Why Astera Labs, Inc. (ALAB) is a Strong Momentum Stock
Here's Why Astera Labs, Inc. (ALAB) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Here's Why Werner Enterprises (WERN) is a Strong Momentum Stock
Here's Why Werner Enterprises (WERN) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why Zebra Technologies (ZBRA) is a Top Momentum Stock for the Long-Term
Why Zebra Technologies (ZBRA) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Here's Why Veracyte (VCYT) is a Strong Momentum Stock
Here's Why Veracyte (VCYT) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why Host Hotels (HST) is a Top Momentum Stock for the Long-Term
Why Host Hotels (HST) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Why SM Energy (SM) is a Top Momentum Stock for the Long-Term
Why SM Energy (SM) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why Estee Lauder (EL) is a Strong Momentum Stock
Here's Why Estee Lauder (EL) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Here's Why General Motors (GM) is a Strong Momentum Stock
Here's Why General Motors (GM) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Here's Why Valero Energy (VLO) is a Strong Momentum Stock
Here's Why Valero Energy (VLO) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates